MYP_082622
Human C1-esterase inhibitor
Hemostasis
▸
Fibrinolytic activity
Therapeutic / Biomedical activity
▸
Enzyme replacement therapy
Standard
500 amino acids
C2458H3933N641O757S18
Standard
MASRLTLLTLLLLLLAGDRASSNPNATSSSSQDPESLQDRGEGKVATTVISKMLFVEPILEVSSLPTTNSTTNSATKITANTTDEPTTQPTTEPTTQPTIQPTQPTTQLPTDSPTQPTTGSFCPGPVTLCSDLESHSTEAVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFTTKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNNSDANLELINTWVAKNTNNKISRLLDSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVARTLLVFEVQQPFLFVLWDQQHKFPVFMGRVYDPRA
55153.53 Da
6.09
-4.61
-5.50
-0.0092
-0.12
0.73
0.06
33.71
89.70
0.0680
26930.00
27180.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0047489
VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Coagulation factor
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Coagulation factor replacement
Thrombolytic
Fibrinolytic
The half life of a 50 IU/kg dose is 2.4 ± 0.6 h, while the half life of a 100 IU/kg dose is 2.7 ± 0.3 h.[L16591] Subcutaneous administration produces a half life of 199.6 hours.[A19661]
RECORD: Rec_0230546
VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Coagulation factor
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Coagulation factor replacement
Enzyme replacement
Thrombolytic
Fibrinolytic
The half life of a 50 IU/kg dose is 2.4 ± 0.6 h, while the half life of a 100 IU/kg dose is 2.7 ± 0.3 h.[L16591] Subcutaneous administration produces a half life of 199.6 hours.[A19661]